,
Greenberg, Jason H.
Devarajan, Prasad
Thiessen-Philbrook, Heather R.
Krawczeski, Catherine
Parikh, Chirag R.
Zappitelli, Michael
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL085757)
National Institute of Diabetes and Digestive and Kidney Diseases (K08DK110536)
National Institute of Diabetes and Digestive and Kidney Diseases (K24DK090203)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK079310-07)
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK082185)
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK082185)
National Institute of Diabetes and Digestive and Kidney Diseases (P50DK096418)
Article History
Received: 8 September 2017
Revised: 22 December 2017
Accepted: 8 January 2018
First Online: 6 March 2018
Compliance with ethical standards
: Informed consent was obtained from parents or legal guardians, along with assent, when appropriate, from children. This study was approved by the institutional review board of each participating institution.
: Prasad Devarajan reports being a coinventor on the neutrophil gelatinase–associated lipocalin patent. No other disclosures are reported.